SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending due to anticipation surrounding its earnings report, with the community actively discussing revenue expectations, EPS, and guidance updates. Community members are debating whether the stock will experience a post-earnings surge or a "sell the news" pullback, a pattern observed in previous earnings cycles. The broader context includes potential tailwinds from expected rate cuts and the possibility of S&P 500 inclusion.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending due to a new partnership with OpenAI, with the community bullish on its potential impact on future payment infrastructure and driving the stock price higher. Investors are also anticipating upcoming earnings, hoping for positive results to further fuel the upward momentum. Discussions include potential price targets and the possibility of a short squeeze.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community anticipates potential ETF approvals and discusses the overall positive sentiment surrounding the crypto market. Key talking points include staking opportunities and the potential for Solana to reach new all-time highs, driving excitement around related meme coins like WAGMI. The launch of Bitwise Solana $SOL staking ETF is expected to go live tomorrow Oct 28th.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members express bullish sentiment, particularly alongside $SOL. Discussions frequently mention 'PUMP' and highlight the coin's mission, with some suggesting it's poised for a significant run. The community emphasizes holding and accumulating, anticipating potential gains within the Solana ecosystem.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as investors discuss its upcoming earnings report and potential impact on the healthcare sector. Community members are weighing in on whether the company can maintain its guidance amid industry-wide cost pressures, and some anticipate a positive reaction based on Warren Buffett's investment and potential for a strong outlook. Traders are also closely watching for news related to ACA subsidies and the DOJ case, which could act as catalysts.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors digest recent earnings and guidance, with community sentiment split between those seeing a buying opportunity and those anticipating further declines. Discussions revolve around the company's cost-cutting measures, Q4 revenue outlook, and the sustainability of its dividend yield. The broader context includes concerns about demand, labor costs, and competition in the logistics sector.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as discussions swirl around the potential launch of a Hedera ETF, with the community anticipating increased institutional investment and broader market exposure; some community members highlight Hedera's enterprise use cases and real-world adoption as key factors driving positive sentiment, while others are wary of potential short-term pullbacks or rug pulls.

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner on April 1, 2009 and is headquartered in Austin, TX.

Genprex Inc

Genprex (GNPX) is trending due to positive preclinical data on its Reqorsa gene therapy for lung cancer, presented at a recent conference. While some investors express optimism about the low float and potential for a squeeze, others are wary of potential dilution following a reverse stock split. Community discussion includes speculation on upcoming news and the company's financial strategy.

Pump.fun

Pump.fun ($PUMP) is trending amid discussions about potential breakouts and community support on the Solana blockchain. There's a strong sense of optimism with many using the hashtag $WAGMI (We're All Gonna Make It), though some caution against excessive spam. The community is focused on long-term growth and shared success within the $SOL ecosystem.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco ($CCJ) is trending amid broader discussion around nuclear energy's role in powering AI and data centers, with some analysts raising price targets. Community chatter highlights the stock's recent performance and potential breakout, while others point to technical indicators and potential pullbacks. The focus remains on Cameco's position in the uranium market and its ties to Westinghouse.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$QGEN $INCY $ILMN  
 
Qiagen, Incyte announce collaboration to develop companion diagnostics  
 
QIAGEN (QGEN) and Incyte (INCY) announced a new global collaboration to develop a novel diagnostic panel to support Incyte&#39;s extensive portfolio of investigational therapies for patients with myeloproliferative neoplasms, a group of rare blood cancers, including Incyte&#39;s monoclonal antibody INCA033989, targeting mutant calreticulin, which is being developed in myelofibrosis and essential thrombocythemia.  
 
Under the terms of the Master Collaboration Agreement with Incyte, QIAGEN will develop a multimodal panel using next-generation sequencing technology for detecting clinically relevant gene alterations in hematological malignancies. The panel will be validated using the next-generation sequencing technology and the Illumina NextSeq 550Dx platform as part of QIAGEN&#39;s partnership with Illumina (ILMN) to leverage its NGS diagnostic platforms for patient testing by laboratories worldwide.  
 
QIAGEN will support regulatory submission processes and market access activities across the United States, European Union and Asia-Pacific regions.

StockTwits Web

Qiagen NV

Incyte Corp.

Illumina Inc

  
 
Qiagen, Incyte announce collaboration to develop companion diagnostics  
 
QIAGEN (QGEN) and Incyte (INCY) announced a new global collaboration to develop a novel diagnostic panel to support Incyte's extensive portfolio of investigational therapies for patients with myeloproliferative neoplasms, a group of rare blood cancers, including Incyte's monoclonal antibody INCA033989, targeting mutant calreticulin, which is being developed in myelofibrosis and essential thrombocythemia.  
 
Under the terms of the Master Collaboration Agreement with Incyte, QIAGEN will develop a multimodal panel using next-generation sequencing technology for detecting clinically relevant gene alterations in hematological malignancies. The panel will be validated using the next-generation sequencing technology and the Illumina NextSeq 550Dx platform as part of QIAGEN's partnership with Illumina (ILMN) to leverage its NGS diagnostic platforms for patient testing by laboratories worldwide.  
 
QIAGEN will support regulatory submission processes and market access activities across the United States, European Union and Asia-Pacific regions.